21-10561044-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_199261.4(TPTE):āc.299T>Cā(p.Phe100Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 6/8 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 60)
Exomes š: 0.000016 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
TPTE
NM_199261.4 missense
NM_199261.4 missense
Scores
7
Clinical Significance
Conservation
PhyloP100: 1.57
Genes affected
TPTE (HGNC:12023): (transmembrane phosphatase with tensin homology) This gene encodes a PTEN-related tyrosine phosphatase which may play a role in the signal transduction pathways of the endocrine or spermatogenic function of the testis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13386557).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPTE | NM_199261.4 | c.299T>C | p.Phe100Ser | missense_variant | 10/24 | ENST00000618007.5 | NP_954870.3 | |
TPTE | NM_199259.4 | c.245T>C | p.Phe82Ser | missense_variant | 9/23 | NP_954868.2 | ||
TPTE | NM_199260.4 | c.185T>C | p.Phe62Ser | missense_variant | 8/22 | NP_954869.2 | ||
TPTE | NM_001290224.2 | c.-116T>C | 5_prime_UTR_variant | 5/19 | NP_001277153.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPTE | ENST00000618007.5 | c.299T>C | p.Phe100Ser | missense_variant | 10/24 | 1 | NM_199261.4 | ENSP00000484403 | P2 |
Frequencies
GnomAD3 genomes Cov.: 60
GnomAD3 genomes
Cov.:
60
GnomAD3 exomes AF: 0.0000679 AC: 17AN: 250226Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135306
GnomAD3 exomes
AF:
AC:
17
AN:
250226
Hom.:
AF XY:
AC XY:
5
AN XY:
135306
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000158 AC: 23AN: 1459382Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 725968
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
23
AN:
1459382
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
725968
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 60
GnomAD4 genome
Cov.:
60
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.299T>C (p.F100S) alteration is located in exon 10 (coding exon 7) of the TPTE gene. This alteration results from a T to C substitution at nucleotide position 299, causing the phenylalanine (F) at amino acid position 100 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T;.
LIST_S2
Benign
T;T;T;T
MetaRNN
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Vest4
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at